Shares of Acumen Pharmaceuticals fell after its loss widened and results missed analyst expectations in the third quarter. The stock fell 16% to $2.69 in afternoon trading Tuesday. Shares, which had ...
In a promising development for Alzheimer’s disease diagnostics, Veravas, Inc. and Phanes Biotech have announced their ...
Essence may receive compensation for some links to products and services on this website. Offers may be subject to change ...
An annual storytelling event in Saratoga Springs has grown into a new location in its fifth year. TrueSongs began at Caffè ...
Together people affected by a disease that afflicts one in eight older adults in Florida, they came out to Jacksonville's ...
The Alzheimer's Association is kicking off its annual McGinty Conference this week at the Oregon Convention Center.
Researchers at Baylor College of Medicine, the Jan and Dan Duncan Neurological Research Institute (Duncan NRI) at Texas ...
An anti-Alzheimer's nasal spray that could delay the progress of the disease by years has been developed by scientists at ...
For AbbVie, the failure of a high-profile schizophrenia drug hardly marks its last chance to invest in neuroscience. But the ...
Alzheimer’s affects around 800,000 people in Spain, a disease that presents the carers with challenges and devastating ...
After more than two months of set up and thousands spent on decorations, a Vietnam veteran's dream of lighting up his street ...
Alzheimer’s disease robs patients of so much more than their health. It can rewire their personalities and undermine a ...